MyFinsight
Home
Blog
About
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$212,911K
Free Cash flow
-$89,274K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Purchases of investments
Proceeds from stock option exerc...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Maturities of investments
Net loss
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-69,234
-86,981
-82,175
-142,195
Stock-based compensation expense
16,007
14,453
15,802
29,649
Lease impairment charge
-
-
3,855
0
Impairment of long-lived assets
-
3,856
-
-
Depreciation and amortization
2,022
2,032
2,149
4,132
Premiums and discounts on available-for-sale marketable securities
-2,730
-2,045
-2,188
-4,646
Prepaid expenses and other current assets
3,565
322
-266
2,305
Accounts receivable
-
0
-40,000
40,000
Contract asset
0
0
0
-947
Other non-current assets
-
-
-2,153
-2,725
Accounts payable
8,824
-1,491
-267
-216
Accrued expenses and other current liabilities
-7,209
13,662
664
-6,939
Deferred revenue
-34,365
-2,871
-2,764
26,424
Operating lease right-of-use assets
-615
-596
-708
-1,362
Operating lease liabilities
-1,358
-1,329
-1,297
-2,416
Other non-current assets
-
7,164
-
-
Other non-current liabilities
-
18
-
-
Other assets and liabilities
-1,969
-
-290
106
Net cash used in operating activities
-88,840
-66,747
-27,110
-139,034
Purchase of property and equipment, net
434
106
181
1,162
Purchase of marketable securities
-
1,007,628
-
-
Purchases of investments
-233,199
-
367,558
141,907
Maturities of marketable securities
-
488,016
-
-
Maturities of investments
-250,285
-
132,440
251,705
Proceeds from employee stock purchase plan
-
573
0
1,112
Net cash provided by (used in) investing activities
-142,840
-394,398
-235,299
108,636
Issuance of common stock and accompanying pre-funded warrants from january 2024 public offering, net of issuance costs of 14.9 million
-
0
0
0
Proceeds from issuance of common stock through at-the market sales agreement, net of issuance costs of 1.2 million
-
0
0
0
Issuance of common stock and accompanying pre-funded warrants from august 2024 public offering, net of issuance costs of 12.2 million
-
0
237,294
-237,294
Issuance of common stock and accompanying pre-funded warrants from june 2025 public offering, net of issuance costs of 15.7 million
-
0
-272,671
-
Issuance of common stock from december 2025 public offering, net of issuance costs of 36.2 million
-
-656,230
-
-
Proceeds from stock option exercises
19,194
48,832
4,552
8,237
Payments on finance leases
425
416
419
659
Net cash provided by financing activities
18,769
705,219
39,510
245,984
Net decrease in cash, cash equivalents and restricted cash
-212,911
244,074
-222,899
215,586
Cash, cash equivalents and restricted cash at beginning of period
362,811
118,737
126,050
-
Cash, cash equivalents and restricted cash at end of period
149,900
362,811
118,737
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from stock
option exercises
$19,194K
Net cash provided by
financing activities
$18,769K
Canceled cashflow
$425K
Net decrease in
cash, cash...
-$212,911K
Canceled cashflow
$18,769K
Purchases of investments
-$233,199K
Stock-based compensation
expense
$16,007K
Accounts payable
$8,824K
Depreciation and
amortization
$2,022K
Other assets and
liabilities
-$1,969K
Operating lease
right-of-use assets
-$615K
Payments on finance
leases
$425K
Net cash provided by
(used in) investing...
-$142,840K
Net cash used in
operating activities
-$88,840K
Canceled cashflow
$233,199K
Canceled cashflow
$29,437K
Maturities of investments
-$250,285K
Net loss
-$69,234K
Deferred revenue
-$34,365K
something is missing
-$125,320K
Purchase of property and
equipment, net
$434K
Accrued expenses and
other current...
-$7,209K
Prepaid expenses and
other current assets
$3,565K
Premiums and discounts on
available-for-sale marketable...
-$2,730K
Operating lease
liabilities
-$1,358K
Buy us a coffee